Works (7)

Updated: November 16th, 2025 05:05

2025 article

855 Interim results from a comparative oncology safety study evaluating intravesical chitosan/interleukin-12 immunotherapy in client-owned dogs with invasive urothelial carcinoma

Helein, G. T., Nguyen, T. T., Intile, J. L., Mastromauro, M. L., Vaden, S. A., Hess, P. R., & Zaharoff, D. A. (2025, November 1). Regular and Young Investigator Award Abstracts, Vol. 11.

By: G. Helein n, T. Nguyen n, J. Intile n, M. Mastromauro n, S. Vaden n, P. Hess n, D. Zaharoff n

topics (OpenAlex): Bladder and Urothelial Cancer Treatments; Veterinary Oncology Research; Veterinary Medicine and Surgery
Sources: NC State University Libraries, NC State University Libraries
Added: November 13, 2025

2022 journal article

Doxorubicin for treatment of histiocytic sarcoma in dogs: 31 cases (2003–2017)

Journal of the American Veterinary Medical Association, 260(14), 1827–1833.

By: R. Doka n, S. Suter n, M. Mastromauro n, A. Bennett n & P. Hess n

MeSH headings : Dogs; Animals; Histiocytic Sarcoma / veterinary; Retrospective Studies; Dog Diseases / diagnosis; Doxorubicin / therapeutic use; Treatment Outcome
topics (OpenAlex): Veterinary Oncology Research; Infectious Diseases and Mycology; Oral and Maxillofacial Pathology
TL;DR: Benefits of doxorubicin administration in canine HS are modest, with a limited ORR and delay in tumor progression, and are comparable to effects attained with other single-agent regimens. (via Semantic Scholar)
UN Sustainable Development Goals Color Wheel
UN Sustainable Development Goal Categories
1. No Poverty (OpenAlex)
Sources: Web Of Science, ORCID, NC State University Libraries, Crossref
Added: February 6, 2023

2022 journal article

Pathology in Practice

Journal of the American Veterinary Medical Association, 261(1), 1–3.

By: W. Holl n, D. Barrantes Murillo*, S. Sommer n, K. Lunn n, M. Mastromauro n, A. Berg n, N. Tatiane Terumi n

MeSH headings : Animals; Animal Diseases / diagnosis
topics (OpenAlex): Genetic factors in colorectal cancer; Cholangiocarcinoma and Gallbladder Cancer Studies; Ovarian cancer diagnosis and treatment
Sources: ORCID, Crossref, NC State University Libraries
Added: February 15, 2025

2022 journal article

Pathology in Practice

Journal of the American Veterinary Medical Association, 259(S2), 1–4.

MeSH headings : Animals; Humans; Pathology, Veterinary; United States; Veterinarians
topics (OpenAlex): Microbial infections and disease research; Veterinary Oncology Research
Sources: ORCID, Crossref, NC State University Libraries
Added: February 15, 2025

2021 journal article

What is your diagnosis? Dermal mass in a dog

Veterinary Clinical Pathology, 51(1), 161–163.

By: J. Marin n, H. Mochizuki n, M. Mastromauro n & D. Stowe n

author keywords: ALP cytochemical stain; Canine; Cutaneous; Metastasis; Osteosarcoma
MeSH headings : Animals; Bone Neoplasms / veterinary; Dog Diseases / diagnosis; Dogs; Osteosarcoma / diagnosis; Osteosarcoma / veterinary
topics (OpenAlex): Veterinary Oncology Research; Infectious Diseases and Mycology; Microbial infections and disease research
UN Sustainable Development Goals Color Wheel
UN Sustainable Development Goal Categories
Sources: Web Of Science, ORCID, NC State University Libraries, Crossref
Added: November 5, 2021

2019 journal article

What is your diagnosis? Lymphocytes engulfing erythrocytes in a cat

Veterinary Clinical Pathology, 48(4), 768–770.

By: H. Mochizuki n, E. Sherrick n, M. Mastromauro n & D. Stowe n

author keywords: cell cannibalism; chronic lymphocytic leukemia; erythrophagia; feline; lymphoma
MeSH headings : Animals; Cat Diseases / diagnosis; Cat Diseases / pathology; Cats; Female; Leukemia, Lymphoid / diagnosis; Leukemia, Lymphoid / pathology; Leukemia, Lymphoid / veterinary; Lymphocytes
topics (OpenAlex): Veterinary Oncology Research; Blood groups and transfusion; Complement system in diseases
UN Sustainable Development Goals Color Wheel
UN Sustainable Development Goal Categories
13. Climate Action (Web of Science)
Sources: Web Of Science, ORCID, NC State University Libraries, Crossref
Added: January 21, 2020

2017 journal article

Oral melphalan for the treatment of relapsed canine lymphoma

Veterinary and Comparative Oncology, 16(1), E123–E129.

By: M. Mastromauro n, S. Suter n, M. Hauck n & P. Hess n

author keywords: canine; chemotherapy; lymphoma; melphalan; rescue
MeSH headings : Administration, Oral; Animals; Antineoplastic Agents, Alkylating / administration & dosage; Antineoplastic Agents, Alkylating / adverse effects; Antineoplastic Agents, Alkylating / therapeutic use; Dog Diseases / drug therapy; Dogs; Female; Lymphoma / drug therapy; Lymphoma / veterinary; Male; Melphalan / administration & dosage; Melphalan / adverse effects; Melphalan / therapeutic use; Recurrence; Retrospective Studies
topics (OpenAlex): Veterinary Oncology Research; Infectious Diseases and Mycology; Microbial infections and disease research
TL;DR: Although treatment resulted in limited clinical benefit and non-durable responses, oral melphalan was well-tolerated and may be a reasonable rescue option in cases where minimal effective agents remain. (via Semantic Scholar)
Sources: Web Of Science, ORCID, NC State University Libraries, Crossref
Added: August 6, 2018

Citation Index includes data from a number of different sources. If you have questions about the sources of data in the Citation Index or need a set of data which is free to re-distribute, please contact us.

Certain data included herein are derived from the Web of Science© and InCites© (2026) of Clarivate Analytics. All rights reserved. You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.